Tiribelli M, Latagliata R, Breccia M, Capodanno I, et al. Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic-phase chronic myeloid leukemia: A study from the Registro Italiano LMC and Campus CML. Cancer 2023 Jun 24. doi: 10.1002/cncr.34923.
PMID: 37354090